Etk/BMX is a non-receptor protein tyrosine kinase that requires a functional phosphatidylinositol 3-kinase via the pleckstrin homology domain to be activated by cytokine. In the present study, a conditionally active form of Etk was constructed by fusing the hormonebinding domain of estrogen receptor (ER) to an amino terminus truncated form of Etk, PH⌬1-68Etk, to generate ⌬Etk:ER. In stably transfected Pa-4⌬Etk:ER cells, the activity of ⌬Etk:ER was stimulated within minutes by the treatment of ⌬Etk:ER stimulant, estradiol, and sustained for greater than 24 h. A robust induction in the phosphorylation of signal transducers and activators of transcription (STAT) proteins, including STAT1, STAT3, and STAT5, was accompanied with ⌬Etk:ER activation. Moreover, the conditionally activated Etk stimulated STAT1-and STAT5-dependent reporter activities by ϳ160-and ϳ15-fold, respectively, however, elicited only a modest STAT3-mediated reporter activation. Qualitatively comparable results were obtained in lung A549 cells, indicating that ⌬Etk:ER inducible system could function in an analogous fashion in different epithelial cells. Furthermore, we demonstrated that Etk activation alone augmented cyclin D1 promoter/enhancer activity via its STAT5 response element in both Pa-4⌬Etk:ER and A549 cells. Altogether, these findings support the notion that the activation of Etk kinase is sufficient to transactivate STAT-mediated gene expression. Hence, our inducible ⌬Etk:ER system represents a novel approach to investigate the biochemical events following Etk activation and to evaluate the contribution by kinase activation of Etk alone or in conjunction with other signaling pathway(s) to the ultimate biological responses.
1 also known as BMX, is a non-receptor tyrosine kinase that contains a pleckstrin homology (PH) domain at its amino terminus followed by Src homology SH3 and SH2 domains, and a tyrosine kinase domain (1, 2) (Fig. 1) . Interest in the function and regulation of Etk/BMX activity has been invigorated by the findings that this enzyme belongs to the Tec family of nonreceptor protein-tyrosine kinases including additional members of Btk, Itk, Tec, and Txk (reviewed in Ref. 3) . For example, Etk/BMX compensates for the lack of Btk activity in B-cell receptor signal transduction by reconstituting phospholipase C␥2-dependent responses in Btk-deficient DT40 cells (4) . However, these activities may not be the primary in vivo function of Etk/BMX, since Etk/BMX is predominantly expressed in lung and prostate tissues, as well as in salivary epithelial, endothelial, and granulomonocytic cells (1, 2, and this report), but not in B-cells.
The PH domain, located at the Etk amino terminus, is a protein module that has been found in many signal transduction proteins to mediate either protein-lipid or protein-protein interactions (5) . Activation of PI 3-kinase is a prerequisite for Etk/BMX activation, presumably due to the direct interaction between the resultant lipid product and the Etk/BMX PH domain (6) . Alternatively, it could be an indirect activation event via a PI 3-kinase-dependent kinase. The PH domain of other Tec family members is known to interact with ␤␥ subunits of the heterotrimeric G protein (7) . Mutations in the PH domain of Btk, an Etk/BMX-related non-receptor tyrosine kinase, are responsible for the X chromosome-linked agammaglobulinemia in human and the X chromosome-linked immunodeficiency in mice, where B-cell maturation is blocked (8 -10) . In terms of protein-protein interaction, G␣ 12/13 and protein kinase C have also been demonstrated to interact with the PH domains of Btk and Etk/BMX (11) (12) (13) . These protein-protein interactions are proposed to be essential in modulating Btk and Etk/BMX activity. In addition, a protein tyrosine phosphatase, PTPD1, which was identified by a yeast two-hybrid screen using the Etk PH domain as a bait, is able to enhance STAT3 tyrosine phosphorylation in COS cells. 2 However, based on the elegant genetic studies on Drosophila Btk homologue, Dsrc29A, it is of interest to note that the PH domain of Dsrc29A is dispensable for Drosophila copulation and survival (14) .
It has been shown that Etk is involved in the interleukin-6-dependent signal transduction cascade and its consequent neuroendocrine differentiation in prostate cells (1) and the Srcmediated cell transformation. 3 Recently, Etk was reported to protect prostate carcinoma LNCaP cells against apoptosis in-duced by photodynamic therapy and thapsigargin (15) . The precise biological function of Etk in epithelial cells is not well established. The Etk/BMX-mediated cellular responses have mainly been studied by using a dominant negative form of Etk to attenuate its function (1, 15) or a cytokine stimulation/ antigen cross-linking approach to activate Etk/BMX kinase activities (1, 4) . These studies have yielded important information, however, generally addressed only a particular experimental condition without determining the specificity of each individual signaling cascade. For instance, both cytokine stimulation and antigen cross-linking events can elicit a pleiotropic effect by activating more than one signaling pathway. Indeed, JAK, Src, Ras, and PI 3-kinase signaling pathways are all rapidly activated in response to cytokine stimulation (16 -19) . Concomitant activation of multiple signaling pathways by a stimulant, such as a cytokine, makes it difficult to pursue and define the exact biological role(s) of Etk/BMX activation. Similarly, it has been suggested that the use of dominant-negative constructs in certain biological systems has sometimes yielded apparently confusing information, even turns out to be more the exception than the rule (Ref. 20 and references therein). Furthermore, the unanticipated function(s) of Etk could be overlooked by these approaches.
In this report, we described the construction and characterization of a conditionally active Etk molecule. To achieve this, the DNA fragment encoding the hormone-binding domain of estrogen receptor (ER) (21) was fused in-frame to the 3Ј-end of an Etk variant, PH⌬1-68Etk, to create the ⌬Etk:ER expression construct. While the PH⌬1-68Etk NH 2 terminus deletion mutant exhibited constitutive kinase activity, the catalytic activity of ⌬Etk:ER fusion protein was blocked in the absence of ␤-estradiol (E 2 , a ⌬Etk:ER stimulant). The ⌬Etk:ER activity was induced within 15 to 30 min following E 2 addition and sustained for at least 24 h. This ⌬Etk:ER expression construct, which encodes a conditionally activated version of Etk, was employed to investigate the signal transduction and gene regulation events following Etk activation. Our results shown hereby suggest that the E 2 -inducible form of ⌬Etk:ER represents a unique and useful tool to elucidate the role(s) of Etk/ BMX in modulating cellular signal transduction pathways and subsequent responses in epithelial cells as well as in other cell types.
MATERIALS AND METHODS
Constructs-Standard molecular cloning techniques were used to construct an inducible ⌬Etk:ER chimera. In brief, the hormone-binding domain of human estrogen receptor (hER-HBD) was fused in-frame to an amino terminus truncated form of human Etk, PH⌬1-68Etk, to engineer an E 2 -inducible form of Etk, ⌬Etk:ER. The DNA fragment encoding amino acid residues 69 -674 of Etk was generated by PCR amplification using a primer pair (5Ј-primer, 5Ј-CGGCTCGAGCCAT-GGAGGAGCAGACGCCTGTAGAGAGACAG-3Ј; and 3Ј-primer, 5Ј-GC-CGCTAGCTTATGCTTGTCTTTTTCCCGAAGTGG-3Ј). To facilitate cloning, the respective unique restriction enzyme sites of XhoI and NheI were built in these primers, as underlined. A Kozak sequence with translation initiator ATG was introduced to the 5Ј-primer to facilitate translation initiation of the engineered protein. The 1.8-kilobase PCR product was first cloned into pCR2.1 using a TA cloning kit (Invitrogen, Carlsbad, CA). The insert was subsequently excised from the vector and subcloned into the XhoI/NheI sites of a hER-HBD containing vector pBS-hbER (a gift from Dr. M. McMahon, University of California, San Francisco) to produce a HBD-containing Etk chimera, ⌬Etk:ER. The ⌬Etk:ER fusion fragment was then excised by XhoI and ClaI double digestion and subcloned into XhoI/ClaI sites of a neomycin resistance gene containing expression vector pLNCX (21) . All constructs were verified by restriction enzyme digestions and partial DNA sequence analyses. The STAT5-mediated reporter constructs, 4xp21-SIE2-Luc and 4xp21-SIE2m-Luc, and the TK-promoter reporter, pTK-Luc, were kindly provided by Dr. A. Schonthal (University of Southern California), and the STAT1-mediated reporter construct, 3xLy6E-Luc, was a gift from Dr. W. Li (University of Southern California). The cyclin D1 reporter constructs, -1745-CD-1-Luc, 3xD1-SIE1-Luc, and 3xD1-SIE1m-Luc were generously sent to us from Dr. I. Matsumura (Osaka University).
Cell Culture and Stable Transfection-Rat parotid epithelial cell line Pa-4, also known as the parotid C5 cell, was cultured as described previously (22) . Rat Pa-4⌬Etk:ER cell line was established by transfecting Pa-4 cells with the inducible construct ⌬Etk:ER by the LipofectAMINE-mediated method according to the standard procedure suggested by the manufacturer. After selection with Geneticin (G418, 600 g/ml), the resistant clones were isolated, expanded, and screened by Western analyses for ⌬Etk:ER expression. The clones that ectopically expressed ⌬Etk:ER fusion protein were selected for further studies. Among 10 selected clones, clone Etk8, which exhibited the highest ⌬Etk:ER activity upon E 2 treatment, was employed in this study and hereafter designated as Pa-4⌬Etk:ER cells and was maintained as described previously (22) .
Western Analysis and Immunoprecipitation-Pa-4⌬Etk:ER cells and parental Pa-4 cells were treated with 1 M E 2 for different time periods and lysed with 1 ϫ SDS loading buffer. Approximately 20 g of whole cell extract from each sample was subjected to a 10% SDS-polyacrylamide gel electrophoresis. The immunoblot analyses were carried out as described previously (23) . The anti-PY-STAT and anti-STAT antibodies used were purchased from New England Biolabs (Beverly, MA) and Transduction Laboratories (Lexington, KY), respectively. For immunoprecipitation, cells were lysed in RIPA buffer containing 1 ϫ PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 100 g/ml phenylmethylsulfonyl fluoride, 30 l/ml aprotinin (Sigma), and 1 mM sodium orthovanadate. Subsequently, the ⌬Etk:ER fusion protein was precipitated from the cell lysates with either an anti-ER antibody (HC-20, Santa Cruz, CA) or an anti-phosphotyrosine antibody (4G10, Upstate Biotechnology, Inc., Lake Placid, NY) as described previously (23) and followed by immunoblot analyses using reciprocal antibodies.
Transient Transfection and Luciferase Assays-All the transient transfection experiments were performed using LipofectAMINE TM reagent (Life Technologies, Inc.) as described previously (22), and the plasmid DNA used for the transfection was prepared using the Qiagen kit (Qiagen, Chatsworth, CA) as instructed. A total of 2 g of DNA was used for transient transfection of cells at approximately 80% confluence in a 35-mm Petri dish. Luciferase assays were performed using Dual Luciferase reporter assay system (Promega, Madison, WI), and the luciferase activity was measured by a luminometer (Turner TD-20e). The plasmid pRL-TK, which directs the expression of Renilla luciferase under the control of HSV TK promoter, was co-transfected and utilized as an internal control for normalizing the transfection efficiency.
RESULTS

Construction of Conditionally
Active ⌬Etk:ER Construct-We recently cloned a reverse transcription-PCR fragment from RNAs of rat parotid glands and a rat salivary cell line, Pa-4. The DNA sequences and their derived amino acid sequences of the cloned PCR fragments were more than 95% identical to those corresponding regions in human and mouse Etk/BMX (24, 25) . The degenerated primer pairs were designed, based on known homologous human Etk genomic structure (GenBank accession number AC003669), to encompass several intron/exon junctions in order to rule out the possibility of amplifying DNA contaminant in the PCR reaction. Hence, it is concluded that Etk is expressed in rat parotid glands and salivary Pa-4 cells. To investigate Etk function in epithelial cells, we attempted to establish cell lines expressing conditionally active Etk, of which activity can be regulated.
There are several strategies existing to make a conditionally active kinase construct (26, 27) . We had previous success in using the conditionally active Raf-1, ⌬Raf-1:ER, which was engineered by fusing the kinase domain of Raf-1 with the HBD of human ER, in our studies to characterize the biological function mediated by the Raf-1 kinase activation in epithelial cells (23, 28) . A similar approach was employed to construct a conditionally active Etk for our current studies. It has been reported that the ectopically expressed full-length Etk does not have a potent kinase function by itself; however, the deletion of its PH domain results in a constitutive activation (1). Therefore, an Etk variant with a truncated amino terminus PH domain (PH⌬1-68) was engineered. As expected, the resultant PH⌬1-68Etk was constitutively active when expressed in Pa-4 cells (data not shown). To generate a conditionally active form of Etk, the HBD of human ER was fused in-frame to this amino terminus truncated Etk, PH⌬1-68Etk (Fig. 1) . Subsequently, the DNA fragment encoding the fusion protein was subcloned into an expression vector carrying a neomycin resistance gene to create ⌬Etk:ER expression construct. As predicted, the kinase activity of ⌬Etk:ER chimeric protein was exclusively dependent upon E 2 treatment and independent of the input from other signaling pathways, such as PI 3-kinase or JAK activation following cytokine stimulation (data not shown).
Characterization of the Stably Transfected Pa-4⌬Etk:ER Cell Line-To investigate the primary biochemical events following Etk activation, Pa-4 cells were stably transfected with ⌬Etk:ER expression construct. The phosphorylation of Tyr 566 in Etk has been characterized as a hallmark for Etk activation. Hence, a clone of cells exhibiting the highest stimulated ⌬Etk:ER autophosphorylation, as assessed by Western analysis with an antiphosphotyrosine (anti-Tyr(P)) antibody (data not shown), was selected for further studies and hereafter referred to as Pa4⌬Etk:ER. Based on our preliminary results, the anti-human ER antibody recognized exclusively the ⌬Etk:ER fusion protein in Pa-4⌬Etk:ER cell lysates. This antibody was employed to immunoprecipitate the ⌬Etk:ER fusion protein to investigate the nature of E 2 -dependent ⌬Etk:ER activation. Accordingly, the ⌬Etk:ER protein was first immunoprecipitated by the anti-ER antibody from lysates derived from each time point before or after 1 M E 2 exposure. These immunoprecipitates were further analyzed by Western blot and probed with an antiTyr(P) antibody to detect ⌬Etk:ER auto-tyrosine phosphorylation ( Fig. 2A) . We found that the tyrosine phosphorylation of ⌬Etk:ER was elicited by exposing Pa-4⌬Etk:ER cells to the ⌬Etk:ER stimulant, E 2 , for only 15-30 min and the phosphorylation signal persisted throughout the 4 h of treatment.
To confirm that the tyrosine phosphorylation of ⌬Etk:ER was E 2 -dependent and to investigate the duration of ⌬Etk:ER stimulation, immunoprecipitations were carried out with an antiTyr(P) antibody in a separate experiment. Western blots of the immunoprecipitates were then probed with an ER-specific antibody, as shown in Fig. 2B . A comparable E 2 -dependent ⌬Et-k:ER phosphorylation pattern was obtained and the level of phosphorylation sustained for 24 h. Taken together, as shown in Fig. 2D , the tyrosine phosphorylation of ⌬Etk:ER was readily induced within 30 min of E 2 treatment and a further elevation was observed with longer exposure to the ⌬Etk:ER stimulant. The level of tyrosine phosphorylation reached the maximum, approximately 60-fold over basal level, following 8 h of stimulation. This sustained activation of ⌬Etk:ER then lasted for 24 h with a gradual decrease. In contrast, the tyrosine phosphorylation of ⌬Etk:ER in Pa-4⌬Etk:ER cells treated with vehicle alone or prior to treatment was not detected by both approaches.
The ⌬Etk:ER protein expression level was also analyzed over the 24-h course of treatment by immunoblotting using an anti-ER antibody. As shown in Fig. 2C , E 2 treatment elicited a rather modest, if any, increase in the ⌬Etk:ER fusion protein level (upper panel) when compared with the corresponding eIF-2␣ level, which served as an internal control for sample loading (lower panel). Hence, it unambiguously excludes the possibility that the robust increase in the ⌬Etk:ER autophosphorylation signal detected in Fig. 2, A and B , is caused by an increase in ⌬Etk:ER protein expression level. Moreover, we propose that a direct activation of ⌬Etk:ER kinase activity entails the ⌬Etk:ER tyrosine phosphorylation.
The Conditionally Active Etk Stimulates STAT1, STAT3, and STAT5 Tyrosine Phosphorylation-We subsequently assessed whether conditionally active ⌬Etk:ER alone would be sufficient, independent of cytokine stimulation, to modulate gene expression. The cytokine-activated Etk/BMX has previously been shown to stimulate STAT signaling pathway activation in COS cells (13) . STAT tyrosine phosphorylation is obligatory for STAT activation, which could be detected by a change in the immunoreactivity by using antibodies against tyrosine-phosphorylated STAT (29) . Individual lysate was prepared from Pa-4⌬Etk:ER cells that had been treated with E 2 for up to 24 h to test the hypothesis that E 2 -bound ⌬Etk:ER chimera stimulates the downstream STAT signaling pathway via its tyrosine kinase function. These lysates were then analyzed by probing the Western blots with the specific antiserum recognizing tyrosine-phosphorylated STAT1, STAT3, and STAT5, respectively.
A time-dependent increase in the STAT1, STAT3, and STAT5 tyrosine phosphorylation levels was notable in lysates from E 2 -treated Pa-4⌬Etk:ER cells (Fig. 3) . As shown in Fig. 3 , the E 2 -stimulated phosphorylation event was delayed for 1 to 2 h following stimulation, reached a maximum at approximately 12 h post-treatment, and decreased thereafter. The control blots demonstrated a consistent level of individual STAT proteins in Pa-4⌬Etk:ER cell lysates at each time point. It was apparent that both STAT1␣ and STAT1␤ were tyrosinephosphorylated judging from the Western analyses (top panel, Fig. 3A) , whereas the nature of STAT5 (STAT5A or STAT5B) in salivary cells was unclear. By comparing the kinetics of STAT phosphorylation and ⌬Etk:ER induction, we conclude that the STAT activation event occurs downstream of ⌬Etk:ER activation. Furthermore, the different intensities observed among individual immunoreactivities that were detected by each antityrosine-phosphorylated STAT-specific antibody may have resulted from different sensitivities of each antibody employed. Conceivably, the induction of tyrosine phosphorylation of each STAT by Etk could be even faster than demonstrated. Moreover, that E 2 treatment did not result in any detectable STAT tyrosine phosphorylation in parental Pa-4 cells (data not shown) rules out the possibility that a putative E 2 -dependent tyrosine kinase stimulates STAT tyrosine phosphorylation directly.
Activation of STAT-responsive Gene Expression-To establish that Etk activation alone is capable of stimulating STATmediated gene expression, transient transfection and reporter gene assays were performed. Pa-4⌬Etk:ER cells were first transfected with 3xLy6E-GasLuc (a reporter gene for STAT1) (30), pLucTKS3 (a reporter gene for STAT3) (31) , and 4xp21-SIE2-Luc (a reporter gene for STAT5) (32), then stimulated with E 2 , and followed by luciferase assays. As shown in Fig. 4A , activated Etk was able to reproducibly induce the STAT1 and STAT5 reporter activities by more than 160-and ϳ15-fold, respectively, over the basal level. In addition, luciferase activities from the construct, 4xp21-SIE2m, carrying mutated STAT5 recognition sites, and the parental pTK-Luc construct were not elevated by Etk stimulation, indicating that the observed enhancing effect was a result of specific DNA-protein interaction between the tyrosine-phosphorylated STAT1/ STAT5 and their response elements, respectively. Moreover, Etk activation rendered a greater stimulation on the STAT1-response element over the STAT5-driven reporter construct. The reason for this differential induction is not clear, although highly reproducible. Together, we concluded that Etk-mediated phosphorylation events are sufficient to transactivate the STAT1-/STAT5-response element-mediated reporter activation.
By contrast, the luciferase activity from pLucTKS3 (a reporter gene for STAT3) was only moderately enhanced by the activated ⌬Etk:ER (Fig. 4A) . In a separate experiment, the overexpression of JAK2 was able to enhance the pLucTKS3 activity by 30-fold (Fig. 4C) . Since a specific anti-phospho-STAT3 (Tyr 705 ) antibody was utilized in our studies shown in Fig. 3 , the Tyr 705 residue of endogenous STAT3 was assumed to be phosphorylated upon Etk activation. However, this Etkstimulated STAT3, when compared with the JAK2-activated STAT3, appeared to have relatively modest transactivation ability. This is unanticipated, but with a precedent (Ref. 30 , and see "Discussion"). Similar to that in Pa-4 cells, Etk stimulated the STAT1/STAT5, but not the STAT3-mediated reporter activation to a great extent in lung epithelial A549 cells (Fig.  4B) , suggesting that the ⌬Etk:ER inducible system could function in an analogous fashion in different epithelial cells.
To assure that Etk activation alone was sufficient to modulate STAT-response element in its native context, we determined whether E 2 -activated ⌬Etk:ER chimera alone could induce the activation of cyclin D1 reporter construct, Ϫ1745-CD-1-Luc, in Pa-4⌬Etk:ER cells. As shown in Fig. 5 , Etk activation Pa-4⌬Etk:ER cells were transfected with 1.9 g of 3xLy6E-Luc, 4xp21-SIE2-Luc, 4xp21-SIE2m-Luc, pLucTKS3, and pTK-Luc, respectively. The Renilla luciferase pRL-TK plasmid, in the amount of 0.1 g, was co-transfected as an indicator to normalize transfection efficiency. Six hours after the start of transfection, cells were cultured in the fresh medium containing either 1 M E 2 to activate ⌬Etk:ER (ϩEtk) or vehicle (ϪEtk) for 16 h. Both firefly and Renilla luciferase activities were measured simultaneously using Dual Luciferase TM Assay System (Promega). The relative luciferase activity from firefly luciferase reporter gene shown in each group of transfected cells was determined and normalized with the indicator Renilla luciferase activity. Each value shown is the mean Ϯ S.E. based on three independent transfection experiments. Error bars (S.E.) represent the standard error of the mean. B, Etk acts on A549 cells in an analogous manner. A549 cells were transiently transfected with 0.7 g of ⌬Etk:ER, 1.2 g of the reporter gene indicated, and 0.1 g of pRL-TK by the LipofectAMINE-mediated method. The cell treatment, the luciferase assays and data analyses were carried out as described in the legend to Fig. 4A . C, JAK2 activates STAT3-response element activity. Reporter construct pLucTKS3 (1.2 g) was co-transfected with either empty vector, pCMV (0.7 g), or JAK2 expression construct (0.7 g) in Pa-4⌬Etk:ER cells. The cell treatment, the luciferase assays and data analyses were carried out as described in the legend to Fig. 4A .
FIG. 5. Etk induces cyclin D1 expression by stimulating STAT5-response element.
A, Etk activates cyclin D1 promoter/enhancer activity via a STAT5-dependent mechanism in Pa-4⌬Etk:ER cells. Pa-4⌬Etk:ER cells were transfected with 1.9 g of Ϫ1745-CD-1-Luc, 3xD1-SIE1, and 3xD1-SIE1m, respectively. The transfection, cell treatment, luciferase assays, and data analyses were carried out as described in the legend to Fig.  4A . B, Etk acts on A549 cells in an analogous manner. The transfection, cell treatment, luciferase assays, and data analyses were carried out as described in the legend to Fig. 4B. ties. Furthermore, we postulated that the previously identified STAT5-binding motif (D1-SIE1) at Ϫ481 base pair of cyclin D1 5Ј-flanking region can be transactivated by Etk. To test this possibility, the reporter construct harboring either three tandem repeats of D1-SIE1 or D1-SIE1m (with site-specific mutations on all STAT5 recognition sites) of cyclin D1, upstream of the minimal JUN B promoter, was transiently transfected in Pa-4⌬Etk:ER cells. As predicted, the 3xD1-SIE1-Luc activity was stimulated greater than 25-fold by Etk activation (Fig. 5A) . The site-specific mutations on SIE1 (3xD1-SIE1m) almost completely abrogated the observed induction by Etk activation. The fold induction of 3xD1-SIE1-Luc activity by ⌬Etk:ER was higher than that of Ϫ1745-CD-1-Luc, since three copies of STAT5-binding motif were engineered in 3xD1-SIE1-Luc construct. A similar observation was also evident by transient co-transfection studies in A549 cells (Fig. 5B) . DISCUSSION We sought to design a conditionally active Etk that could serve as a useful model to provide insights into the Etk function and to determine the biochemical events following Etk activation. To this end, we have demonstrated that fusion of the human ER HBD to an activated form of Etk (PH⌬1-68Etk) renders the tyrosine kinase activity of this chimeric protein cytokine/growth factor-independent, but E 2 -dependent. Using E 2 as a ⌬Etk:ER activator, kinase activity of the chimera, assessed by its tyrosine phosphorylation profile, can be rapidly turned on in the stably transfected Pa-4⌬Etk:ER cells (Fig. 2) . This observation is consistent with the previously proposed model (34) , in which E 2 binding to the HBD stimulates the release of Hsp 90 from the HBD of chimera. It then allows for the access of other protein(s), such as STAT, to the ⌬Etk:ER molecule for subsequent activation. This model also explains the possible scenario by which E 2 -bound ⌬Etk:ER chimera is able to homodimerize, and the dimerization is sufficient to result in trans-Tyr 566 phosphorylation of Etk and its consequent activation.
The STAT proteins belong to a family of latent transcription factors that transmit signals from activated cytokine/growth factor receptors to the nucleus (35, 36) . All STAT members contain a SH2 domain allowing their selective recruitment to the activated receptor kinase complex. The JAK-dependent tyrosine phosphorylation is originally proposed to be the essential element of signal transduction cascade to stimulate STAT activation and its ultimate responses by most, if not all, cytokines and growth factors (36) . However, it is later discovered that cytokine/growth factor-activated receptors usually evoke simultaneous activation of multiple signaling pathway (37) . For example, ␤-interferon and oncostatin M activate both JAK/ STAT and Raf/ERK signaling cascades concurrently for their maximal action (38) . Thus, determining the contribution by each signaling pathway to the eventual phenotypic outcomes is a challenging task. Using the conditionally active ⌬Etk:ER construct, it is possible to exclusively activate STAT-mediated responses without the interference from other signaling molecules.
The PH domains have been described in many proteins involved in membrane localization, signal transduction, and interacting with cytoskeletal structure (39 -41) . By utilizing this inducible ⌬Etk:ER construct, we were able to distinguish the putative contribution by Etk kinase function from the effect mediated through its protein-protein interaction via the PH domain. Our data reported herein clearly suggest that once Etk is activated, the PH domain is dispensable for its biological function, such as STAT phosphorylation and subsequent gene activation, because the PH domain has been partially truncated in the ⌬Etk:ER chimera. However, it requires further studies to determine intracellular localization of the activated ⌬Etk:ER. Altogether, it is tempting to postulate that although the PH domain is required for Etk activation by cytokine/ growth factor via the PI 3-kinase, the already activated Etk is capable of recruiting its substrates through protein-protein interaction via the SH2 or SH3 domain for subsequent activation. The precise function of PH and other domains of Etk in Etk-mediated signal transduction and gene regulation program remains to be established.
In the present studies, we demonstrated conclusively that Etk activation evoked the transcriptional stimulation of STAT1-and STAT5-dependent reporter constructs in both stably transfected Pa-4⌬Etk:ER cells (Fig. 4A) and ⌬Etk:ER transiently transfected A549 cells (Fig. 4B) . In Pa-4⌬Etk:ER cells, the duration required for stimulating STAT phosphorylation was consistent with the time frame needed to induce Etk enzymatic activity (Figs. 2 and 3) . Conceivably, the stimulated Etk tyrosine kinase activity, rather than a secondary event, directly mediates the STAT activation. An unanticipated and intriguing finding of this study was that the fold induction on STAT3-responsive reporter by the Etk was lower than that via the JAK2 activation. The reason that Etk-stimulated STAT3 does not have a full transactivational ability is still unclear. It is possible that further modification, such as serine phosphorylation, in addition to tyrosine phosphorylation, is required for STAT3 to display the maximal transactivation activity. For example, a S727A mutation in STAT3 is reported to attenuate IFN-␣-stimulated STAT3 reporter activation from 20-to 8-fold, suggesting that the Ser 727 phosphorylation in STAT3 is necessary for the optimal transactivation ability (30) . In HL-60 cells, granulocyte-macrophage colony-stimulating factor-induced inhibitory serine/threonine phosphorylation (on residue(s) other thanSer 727 )preventedthegranulocytecolony-stimulatingfactordependent nuclear translocation of tyrosine-phosphorylated STAT3 (42) . It is possible that the lack of stimulatory Ser 727 phosphorylation activity or the presence of interfering serine/ threonine phosphorylation event via an analogous aforementioned mechanism in our inducible Etk paradigm could account for this low level of enhancement on the STAT3 transactivation ability. Together, it is plausible that the Etk-stimulated STAT3 phosphorylation event (Fig. 3) is not sufficient to transactivate STAT3-dependent gene expression and Etk acts mechanistically different from JAK2.
The cytokine/growth factor-stimulated STAT activation via tyrosine phosphorylation is typically transient (36) . The average half-life of tyrosine-phosphorylated STAT is relatively short, mostly less than 2 h in many cell lines reported (43) . Hence, it is conceivable that the unusually sustained induction on Etk kinase activity in E 2 -treated Pa-4⌬Etk:ER cells causes the prolonged STAT activation. It is noteworthy that the STAT tyrosine phosphorylation level started to decline after 12 h of treatment (Fig. 3) even in the presence of the activated ⌬Etk:ER (Fig. 2) . This phenomenon could be explained by that the protein tyrosine phosphatase activity is also induced by Etk activation to attenuate its own effect as an autoregulatory process. Alternatively, enhanced protein degradation caused by Etk activation would be responsible for the accelerated turnover of STAT protein. Based on the Western analysis illustrated in Fig. 3 , it appeared that the expression levels of STAT1, STAT3, and STAT5 were not affected by the Etk activation during the course of the experiment. Hence, the diminished signals of activated STAT are unlikely to be the result of enhanced STAT protein degradation caused by Etk activation or E 2 treatment.
Regulation of tyrosine phosphorylation (activation) and dephosphorylation (deactivation) of STAT modulates the dura-tion and potency of various cytokine/growth factor-mediated signaling pathways and their ultimate biological manifestation. Transient STAT activation results in rapid responses, whereas a sustained STAT activation leads to a prolonged period of gene induction and enhanced biological activity. It is possible that two ligands would activate the level of the same STAT protein differentially over different periods of time. This would result in differential transcriptional outcomes, and lead to distinct physiological phenomena. The net regulation of tyrosine phosphorylation/dephosphorylation is orchestrated by a coordinated action of protein tyrosine kinase(s) and protein tyrosine phosphatase(s) (44) . Thus, the modulation of either protein tyrosine kinase(s) or protein tyrosine phosphatase(s) function renders an imbalance in the overall activities of these two counteracting modules, and subsequently leads to an altered biological response. Little information on the Etk-coupled endogenous gene expression is available to date. As shown in Fig. 5 , we demonstrated that the ⌬Etk:ER chimera stimulates the promoter/enhancer activity of cyclin D1, which is a prototype interleukin-3/STAT5-responsive gene and is demonstrated to be involved in cytokine-dependent cell proliferation (33) . The transcriptional regulation of cyclin D1 has been intensely studied and constellations of transcription factor-binding sites other than the STAT5 binding motif have been identified. In this regard, the conditionally active ⌬Etk:ER system would represent a unique and powerful approach to unravel both the immediate-early and sustained STAT-mediated gene responses.
Our results presented herein constitute the first direct physical evidence that tyrosine phosphorylation mediated by the activated Etk alone is sufficient to activate the latent STAT1 and STAT5, and subsequently stimulate STAT1/STAT5 responsive reporter expression in rat salivary and human lung epithelial cells. This conclusion is based on our results that gene activation by the conditionally activated ⌬Etk:ER occurs independent from the input of other signaling molecules. Furthermore, an intact PH domain at the Etk amino terminus is not required for the demonstrated STAT activation and reporter stimulation. We have also demonstrated that the activated Etk mediates a transcriptional stimulation on cyclin D1 promoter/enhancer. This observation suggests the possibility that cyclin D1 is a downstream target gene of Etk activation. Together, these findings provide novel insight into the putative Etk function in epithelial cells. In summary, the conditionally active ⌬Etk:ER chimera not only represents a novel, inducible approach to specifically investigate Etk-mediated biochemical and cellular events but should prove useful in establishing the contribution from Etk alone or in conjunction with other signaling pathway(s) to the ultimate phenotypic responses.
